| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 654236 | Null | 0.0181211508101519 | -0.23994969 |
| NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.0181211508101519 | -0.05827304 |
| NSC 699148 | Null | 0.0181211508101519 | 0.38019011 |
| NSC 716768 | Null | 0.0181211508101519 | 0.47380004 |
| NSC 720194 | Null | 0.0181211508101519 | 0.11676803 |
| NSC 740276 | 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide | 0.0181211508101519 | 0.26205906 |
| NSC 740504 | 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.0181211508101519 | 0.23211963 |
| NSC 754328 | Null | 0.0181211508101519 | -0.20047321 |
| NSC 757949 | (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.0181211508101519 | -0.22034729 |
| NSC 96996 | B 169 | 0.0181211508101519 | 0.21052163 |